UK markets closed
  • FTSE 100

    7,027.58
    +59.28 (+0.85%)
     
  • FTSE 250

    22,883.39
    +206.09 (+0.91%)
     
  • AIM

    1,232.54
    +4.45 (+0.36%)
     
  • GBP/EUR

    1.1675
    -0.0013 (-0.11%)
     
  • GBP/USD

    1.3769
    +0.0002 (+0.01%)
     
  • BTC-GBP

    24,996.72
    +258.89 (+1.05%)
     
  • CMC Crypto 200

    786.33
    -7.40 (-0.93%)
     
  • S&P 500

    4,411.79
    +44.31 (+1.01%)
     
  • DOW

    35,061.55
    +238.15 (+0.68%)
     
  • CRUDE OIL

    72.17
    +0.10 (+0.14%)
     
  • GOLD FUTURES

    1,802.10
    +0.30 (+0.02%)
     
  • NIKKEI 225

    27,548.00
    +159.80 (+0.58%)
     
  • HANG SENG

    27,321.98
    -401.82 (-1.45%)
     
  • DAX

    15,669.29
    +154.79 (+1.00%)
     
  • CAC 40

    6,568.82
    +87.23 (+1.35%)
     

Global Protein Engineering Market to Reach $3.8 Billion by 2027

·25-min read

Abstract: - Global Protein Engineering Market to Reach $3. 8 Billion by 2027. - Amid the COVID-19 crisis, the global market for Protein Engineering estimated at US$1. 4 Billion in the year 2020, is projected to reach a revised size of US$3.

New York, June 28, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Protein Engineering Industry" - https://www.reportlinker.com/p06032695/?utm_source=GNW
8 Billion by 2027, growing at a CAGR of 14.7% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 14.1% CAGR and reach US$1.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 14.9% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $389.9 Million, While China is Forecast to Grow at 19% CAGR
- The Protein Engineering market in the U.S. is estimated at US$389.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$850.4 Million by the year 2027 trailing a CAGR of 18.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.5% and 12.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 11.6% CAGR.
- Software & Services Segment to Record 15.7% CAGR
- In the global Software & Services segment, USA, Canada, Japan, China and Europe will drive the 14.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$239.8 Million in the year 2020 will reach a projected size of US$628.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$575.1 Million by the year 2027, while Latin America will expand at a 17.4% CAGR through the analysis period.

- Select Competitors (Total 34 Featured) -

  • Abzena, Ltd.

  • Agilent Technologies, Inc.

  • Bio-Rad Laboratories, Inc.

  • Bruker Corporation

  • Codexis, Inc.

  • Creative Biolabs

  • Danaher Corporation

  • Enantis S.R.O.

  • GE Healthcare

  • Genscript Biotech Corporation

  • Innovagen AB

  • Merck KGaA

  • New England Biolabs, Inc.

  • Perkinelmer, Inc.

  • Phynexus, Inc. (A Part of Biotage)

  • Promega Corporation

  • Proteogenix

  • Takara Bio, Inc.

  • Thermo Fisher Scientific, Inc.

  • Waters Corporation




Read the full report: https://www.reportlinker.com/p06032695/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Protein
Engineering by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Protein Engineering by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Protein Engineering by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Reagents by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Reagents by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Reagents by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Software &
Services by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Software & Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Software & Services by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Rational Protein
Design by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Rational Protein Design by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Rational Protein Design
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Directed
Evolution by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Directed Evolution by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Directed Evolution by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Hybrid Approach
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Hybrid Approach by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Hybrid Approach by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Pharma & Biotech
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Pharma & Biotech Companies
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Pharma & Biotech
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 25: World Current & Future Analysis for Contract Research
Organizations by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Contract Research
Organizations by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Contract Research
Organizations by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 28: World Current & Future Analysis for Academic Research
Institutes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Academic Research
Institutes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Academic Research
Institutes by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

III. MARKET ANALYSIS

UNITED STATES
Table 31: USA Current & Future Analysis for Protein Engineering
by Component - Instruments, Reagents and Software & Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Protein Engineering by
Component - Instruments, Reagents and Software & Services
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Protein Engineering by
Component - Percentage Breakdown of Value Sales for
Instruments, Reagents and Software & Services for the Years
2012, 2020 & 2027

Table 34: USA Current & Future Analysis for Protein Engineering
by Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 35: USA Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2012, 2020 & 2027

Table 37: USA Current & Future Analysis for Protein Engineering
by End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 38: USA Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 39: USA 15-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2012, 2020 & 2027

CANADA
Table 40: Canada Current & Future Analysis for Protein
Engineering by Component - Instruments, Reagents and Software &
Services - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 41: Canada Historic Review for Protein Engineering by
Component - Instruments, Reagents and Software & Services
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 42: Canada 15-Year Perspective for Protein Engineering by
Component - Percentage Breakdown of Value Sales for
Instruments, Reagents and Software & Services for the Years
2012, 2020 & 2027

Table 43: Canada Current & Future Analysis for Protein
Engineering by Technology - Rational Protein Design, Directed
Evolution and Hybrid Approach - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 44: Canada Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2012, 2020 & 2027

Table 46: Canada Current & Future Analysis for Protein
Engineering by End-Use - Pharma & Biotech Companies, Contract
Research Organizations and Academic Research Institutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: Canada Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2012, 2020 & 2027

JAPAN
Table 49: Japan Current & Future Analysis for Protein
Engineering by Component - Instruments, Reagents and Software &
Services - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 50: Japan Historic Review for Protein Engineering by
Component - Instruments, Reagents and Software & Services
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 51: Japan 15-Year Perspective for Protein Engineering by
Component - Percentage Breakdown of Value Sales for
Instruments, Reagents and Software & Services for the Years
2012, 2020 & 2027

Table 52: Japan Current & Future Analysis for Protein
Engineering by Technology - Rational Protein Design, Directed
Evolution and Hybrid Approach - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 53: Japan Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2012, 2020 & 2027

Table 55: Japan Current & Future Analysis for Protein
Engineering by End-Use - Pharma & Biotech Companies, Contract
Research Organizations and Academic Research Institutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: Japan Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 57: Japan 15-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2012, 2020 & 2027

CHINA
Table 58: China Current & Future Analysis for Protein
Engineering by Component - Instruments, Reagents and Software &
Services - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for Protein Engineering by
Component - Instruments, Reagents and Software & Services
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Protein Engineering by
Component - Percentage Breakdown of Value Sales for
Instruments, Reagents and Software & Services for the Years
2012, 2020 & 2027

Table 61: China Current & Future Analysis for Protein
Engineering by Technology - Rational Protein Design, Directed
Evolution and Hybrid Approach - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 62: China Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2012, 2020 & 2027

Table 64: China Current & Future Analysis for Protein
Engineering by End-Use - Pharma & Biotech Companies, Contract
Research Organizations and Academic Research Institutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 65: China Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 66: China 15-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2012, 2020 & 2027

EUROPE
Table 67: Europe Current & Future Analysis for Protein
Engineering by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 68: Europe Historic Review for Protein Engineering by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 69: Europe 15-Year Perspective for Protein Engineering by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 70: Europe Current & Future Analysis for Protein
Engineering by Component - Instruments, Reagents and Software &
Services - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Protein Engineering by
Component - Instruments, Reagents and Software & Services
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Protein Engineering by
Component - Percentage Breakdown of Value Sales for
Instruments, Reagents and Software & Services for the Years
2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Protein
Engineering by Technology - Rational Protein Design, Directed
Evolution and Hybrid Approach - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 74: Europe Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Protein
Engineering by End-Use - Pharma & Biotech Companies, Contract
Research Organizations and Academic Research Institutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 77: Europe Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 78: Europe 15-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2012, 2020 & 2027

FRANCE
Table 79: France Current & Future Analysis for Protein
Engineering by Component - Instruments, Reagents and Software &
Services - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 80: France Historic Review for Protein Engineering by
Component - Instruments, Reagents and Software & Services
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 81: France 15-Year Perspective for Protein Engineering by
Component - Percentage Breakdown of Value Sales for
Instruments, Reagents and Software & Services for the Years
2012, 2020 & 2027

Table 82: France Current & Future Analysis for Protein
Engineering by Technology - Rational Protein Design, Directed
Evolution and Hybrid Approach - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 83: France Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 84: France 15-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2012, 2020 & 2027

Table 85: France Current & Future Analysis for Protein
Engineering by End-Use - Pharma & Biotech Companies, Contract
Research Organizations and Academic Research Institutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 86: France Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 87: France 15-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2012, 2020 & 2027

GERMANY
Table 88: Germany Current & Future Analysis for Protein
Engineering by Component - Instruments, Reagents and Software &
Services - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 89: Germany Historic Review for Protein Engineering by
Component - Instruments, Reagents and Software & Services
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 90: Germany 15-Year Perspective for Protein Engineering
by Component - Percentage Breakdown of Value Sales for
Instruments, Reagents and Software & Services for the Years
2012, 2020 & 2027

Table 91: Germany Current & Future Analysis for Protein
Engineering by Technology - Rational Protein Design, Directed
Evolution and Hybrid Approach - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 92: Germany Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 93: Germany 15-Year Perspective for Protein Engineering
by Technology - Percentage Breakdown of Value Sales for
Rational Protein Design, Directed Evolution and Hybrid Approach
for the Years 2012, 2020 & 2027

Table 94: Germany Current & Future Analysis for Protein
Engineering by End-Use - Pharma & Biotech Companies, Contract
Research Organizations and Academic Research Institutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 95: Germany Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 96: Germany 15-Year Perspective for Protein Engineering
by End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2012, 2020 & 2027

ITALY
Table 97: Italy Current & Future Analysis for Protein
Engineering by Component - Instruments, Reagents and Software &
Services - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 98: Italy Historic Review for Protein Engineering by
Component - Instruments, Reagents and Software & Services
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 99: Italy 15-Year Perspective for Protein Engineering by
Component - Percentage Breakdown of Value Sales for
Instruments, Reagents and Software & Services for the Years
2012, 2020 & 2027

Table 100: Italy Current & Future Analysis for Protein
Engineering by Technology - Rational Protein Design, Directed
Evolution and Hybrid Approach - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 101: Italy Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 102: Italy 15-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2012, 2020 & 2027

Table 103: Italy Current & Future Analysis for Protein
Engineering by End-Use - Pharma & Biotech Companies, Contract
Research Organizations and Academic Research Institutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 104: Italy Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 105: Italy 15-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 106: UK Current & Future Analysis for Protein Engineering
by Component - Instruments, Reagents and Software & Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 107: UK Historic Review for Protein Engineering by
Component - Instruments, Reagents and Software & Services
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 108: UK 15-Year Perspective for Protein Engineering by
Component - Percentage Breakdown of Value Sales for
Instruments, Reagents and Software & Services for the Years
2012, 2020 & 2027

Table 109: UK Current & Future Analysis for Protein Engineering
by Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 110: UK Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 111: UK 15-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2012, 2020 & 2027

Table 112: UK Current & Future Analysis for Protein Engineering
by End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 113: UK Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 114: UK 15-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2012, 2020 & 2027

SPAIN
Table 115: Spain Current & Future Analysis for Protein
Engineering by Component - Instruments, Reagents and Software &
Services - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 116: Spain Historic Review for Protein Engineering by
Component - Instruments, Reagents and Software & Services
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 117: Spain 15-Year Perspective for Protein Engineering by
Component - Percentage Breakdown of Value Sales for
Instruments, Reagents and Software & Services for the Years
2012, 2020 & 2027

Table 118: Spain Current & Future Analysis for Protein
Engineering by Technology - Rational Protein Design, Directed
Evolution and Hybrid Approach - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 119: Spain Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 120: Spain 15-Year Perspective for Protein Engineering by
Technology - Percentage Breakdown of Value Sales for Rational
Protein Design, Directed Evolution and Hybrid Approach for the
Years 2012, 2020 & 2027

Table 121: Spain Current & Future Analysis for Protein
Engineering by End-Use - Pharma & Biotech Companies, Contract
Research Organizations and Academic Research Institutes -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 122: Spain Historic Review for Protein Engineering by
End-Use - Pharma & Biotech Companies, Contract Research
Organizations and Academic Research Institutes Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 123: Spain 15-Year Perspective for Protein Engineering by
End-Use - Percentage Breakdown of Value Sales for Pharma &
Biotech Companies, Contract Research Organizations and Academic
Research Institutes for the Years 2012, 2020 & 2027

RUSSIA
Table 124: Russia Current & Future Analysis for Protein
Engineering by Component - Instruments, Reagents and Software &
Services - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 125: Russia Historic Review for Protein Engineering by
Component - Instruments, Reagents and Software & Services
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 126: Russia 15-Year Perspective for Protein Engineering
by Component - Percentage Breakdown of Value Sales for
Instruments, Reagents and Software & Services for the Years
2012, 2020 & 2027

Table 127: Russia Current & Future Analysis for Protein
Engineering by Technology - Rational Protein Design, Directed
Evolution and Hybrid Approach - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR

Table 128: Russia Historic Review for Protein Engineering by
Technology - Rational Protein Design, Directed Evolution and
Hybrid Approach Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 129: Russia 15-Year Perspective for Protein Engineering
by Technology - Percentage Breakdown of Value Sales for
Rational Protein Design, Directed Evolution and Hybrid Approach
for the Years 2012, 2020 & 2027

Table 130: Russia Current & Future Analysis for Protein
Engineering by End-Use - Pharma & Biotech Companies, Contract

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032695/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting